97 results
Page 4 of 5
6-K
EX-99.1
qse7whb biaen
10 Aug 20
FSD Pharma Inc. Announces Closing of US$10 Million Registered Direct Offering to Institutional Investors
12:00am
SUPPL
a3dik5
31 Jul 20
Supplemental materials (foreign)
9:43pm
FWP
hy82exq
31 Jul 20
Free writing prospectus
2:06pm
6-K
EX-99.1
owfoeu77 enz
31 Jul 20
FSD Pharma Inc. Announces US$10 Million Registered Direct Offering
11:17am
6-K
EX-99.1
70gbrwy8 ti79
30 Jul 20
Current report (foreign)
11:40am
6-K
EX-99.1
gd6zm
13 Jul 20
FSD Pharma Announces US$20M At-The-Market Offering
1:08pm
SUPPL
ego7bkm
13 Jul 20
Supplemental materials (foreign)
12:00am
6-K
EX-99.1
t91vzdnnkf36o v03zjw
22 Jun 20
FSD Pharma Reports Favorable Topline Results from Phase 1 First-in-Human Safety and Tolerability Study of Ultramicronized PEA
11:40am
6-K
EX-99.2
x4skq jsg
16 Jun 20
Material Change Report
12:00am
6-K
EX-99.1
7jhag
16 Jun 20
Material Change Report
12:00am
6-K
EX-99.1
nfp8jlpf
9 Jun 20
FSD Pharma Announces Closing of C$10.125 Million Private Placement to Institutional Investors
9:51pm
6-K
EX-99.1
s6tiqmrv7bokq7q 6t
4 Jun 20
FSD Pharma Inc. Announces C$10.125 Million Private Placement
2:33pm
6-K
EX-99.1
0xtnyq
3 Jun 20
FSD Pharma Receives U.S. FDA Approval to design a Phase 2a Clinical Trial to Treat Patients with Suspected or Confirmed COVID-19 Diagnosis
10:41am
6-K
EX-99.1
frh vheid
27 May 20
Current report (foreign)
3:45pm
6-K
EX-99.1
v2gp yf7ja2db1hggj
15 May 20
Management’s Discussion and Analysis of Financial Condition and Results of
10:48am
6-K
EX-99.3
y3epjv j980r
15 May 20
Management’s Discussion and Analysis of Financial Condition and Results of
10:48am
6-K
EX-99.1
4qq8ynsffps
23 Mar 20
FSD Pharma Takes Steps to Mitigate the Impact of COVID-19 on its Cannabis Production Facility in Cobourg, Ontario
4:12pm
6-K
EX-99.1
2yky4dqii3
9 Mar 20
Current report (foreign)
2:36pm
6-K
EX-99.1
2h0brp
4 Mar 20
Current report (foreign)
4:37pm
40-F
EX-99.1
kfu7anjfuzxzkdcp
4 Mar 20
Annual report (Canada)
12:29pm